Zacks Initiates Coverage of Precipio With Outperform Recommendation Thu, Sep 5, 2024, 3:47 PM GMT+2 2 min read 0 In this article: [Yahoo! Finance]
Precipio, Inc. (PRPO)
US:NASDAQ Investor Relations:
precipiodx.com/investors.html
Company Research
Source: Yahoo! Finance
This bullish stance reflects the company's path to profitability and robust positioning within the cancer diagnostics space. Precipio, currently operating from New Haven, CT, focuses on cancer diagnostics. The company, which aims to address the incidence of cancer misdiagnoses through the development of diagnostic products and services, operates clinical laboratories in New Haven, CT, and Omaha, NE, where it provides essential blood cancer diagnostics. Precipio saw a strong sequential revenue increase of 30% in second-quarter 2024, reaching $4.4 million. This growth was fueled by the company's Pathology and Products divisions, both of which are on the cusp of achieving profitability. The Pathology division has already hit breakeven, and the Products arm is expected to follow by the end of fourth-quarter 2024, positioning the company on track for overall profitability soon after. Despite improvements in cash flow, the company's cash reserves remain at $1.3 million, leaving limite
Show less
Read more
Impact Snapshot
Event Time:
PRPO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PRPO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PRPO alerts
High impacting Precipio, Inc. news events
Weekly update
A roundup of the hottest topics
PRPO
News
- Precipio Third Quarter 2024 Earnings: US$0.42 loss per share (vs US$1.04 loss in 3Q 2023) [Yahoo! Finance]Yahoo! Finance
- Precipio Announces Q3-2024 Shareholder Update CallGlobeNewswire
- Precipio Expands Bloodhound™ MPN Panel by Adding CALR Mutation SubtypingGlobeNewswire
- Precipio Announces Employee Stock Option Plan RepricingGlobeNewswire
- Precipio GAAP EPS of -$0.83, revenue of $4.44M [Seeking Alpha]Seeking Alpha
PRPO
Sec Filings
- 11/12/24 - Form 4
- 11/12/24 - Form 144
- 11/7/24 - Form 8-K
- PRPO's page on the SEC website